Qiagen accelerates to bring rare call spread CB before deal rush

September’s expected busy calendar of equity-linked issues in Europe made further progress this week, when Qiagen and Capital Stage sold unusually structured bonds, both of which achieved strong books and priced within their ranges — with no sign of market congestion yet.

  • By Jon Hay
  • 07 Sep 2017
“There are many banks jostling for position as to which deal will come out of the door in which order,” said Martin Haycock, senior partner at Fisch Asset Management in Zurich. “So far, the issuance has been relatively orderly. Deals haven’t fallen on top of each other, and ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 393,149.84 1484 9.02%
2 JPMorgan 359,273.23 1632 8.24%
3 Bank of America Merrill Lynch 345,204.73 1224 7.92%
4 Goldman Sachs 257,794.01 867 5.91%
5 Barclays 253,576.08 996 5.82%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 36,809.20 177 6.30%
2 Deutsche Bank 36,549.85 129 6.26%
3 BNP Paribas 30,786.06 186 5.27%
4 Bank of America Merrill Lynch 30,712.91 97 5.26%
5 Barclays 30,558.69 87 5.23%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 21,398.51 94 8.79%
2 Morgan Stanley 17,574.08 91 7.22%
3 Citi 16,974.50 104 6.97%
4 UBS 16,643.68 66 6.84%
5 Goldman Sachs 16,179.39 87 6.65%